These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26324892)

  • 1. miR-15b/16-2 deletion promotes B-cell malignancies.
    Lovat F; Fassan M; Gasparini P; Rizzotto L; Cascione L; Pizzi M; Vicentini C; Balatti V; Palmieri D; Costinean S; Croce CM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11636-41. PubMed ID: 26324892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockout of both miR-15/16 loci induces acute myeloid leukemia.
    Lovat F; Fassan M; Sacchi D; Ranganathan P; Palamarchuk A; Bill M; Karunasiri M; Gasparini P; Nigita G; Distefano R; Veneziano D; Dorrance AM; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13069-13074. PubMed ID: 30478046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
    Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
    FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
    Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
    Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.
    Ng A; Lovat F; Shih AJ; Ma Y; Pekarsky Y; DiCaro F; Crichton L; Sharma E; Yan XJ; Sun D; Song T; Zou YR; Will B; Croce CM; Chiorazzi N
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2308658120. PubMed ID: 37844234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Kcnq1ot1 attenuates β-cell proliferation and insulin secretion via the miR-15b-5p/Ccnd1 and Ccnd2 axis.
    Li Y; Chen Y; Liu Z; Lin B; Deng X; Xiao Q; Chen Z; Ye H; Chen D; Su Y; Li W; Xu W
    Acta Diabetol; 2022 Jul; 59(7):885-899. PubMed ID: 35347427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
    Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
    Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters.
    Yue J; Tigyi G
    Mamm Genome; 2010 Feb; 21(1-2):88-94. PubMed ID: 20013340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-15a/16-1 and miR-15b/16-2 clusters regulate early B cell development by limiting IL-7 receptor expression.
    Hutter K; Rülicke T; Szabo TG; Andersen L; Villunger A; Herzog S
    Front Immunol; 2022; 13():967914. PubMed ID: 36110849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
    Hanlon K; Rudin CE; Harries LW
    PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.
    Sandhu SK; Fassan M; Volinia S; Lovat F; Balatti V; Pekarsky Y; Croce CM
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18208-13. PubMed ID: 24145403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
    Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
    Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.
    Lovat F; Nigita G; Distefano R; Nakamura T; Gasparini P; Tomasello L; Fadda P; Ibrahimova N; Catricalà S; Palamarchuk A; Caligiuri MA; Gallì A; Malcovati L; Minden MD; Croce CM
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12332-12340. PubMed ID: 32424097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
    Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
    PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-15/16 in CLL.
    Pekarsky Y; Croce CM
    Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
    Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
    Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
    Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.